UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Bronchial endoscopic ultrasound elastography: preliminary feasibility data

The European respiratory journal, 2013-02, Vol.41 (2), p.477-479

2013

Volltextzugriff (PDF)

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

European journal of cancer (1990), 2018-03, Vol.91, p.21-29

2018

Volltextzugriff (PDF)

Gefitinib-Associated Propionibacterium acnes Pleural Empyema

Journal of thoracic oncology, 2008-05, Vol.3 (5), p.556-557

2008

Volltextzugriff (PDF)

FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study

Acta oncologica, 2023-06, Vol.62 (6), p.579-586

2023

Volltextzugriff (PDF)

Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy

Radiology, 2010-02, Vol.254 (2), p.420

2010

Volltextzugriff (PDF)

Real-life use of nivolumab in non-small cell lung cancer: A multicentric cohort to determine its clinical efficacy and predictive factors of early progression

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20543-e20543

2017

Volltextzugriff (PDF)

Antitumoral effect of low molecular weight heparin in localized lung cancer. A randomized phase III controlled trial

Annals of oncology, 2017-11, Vol.28, p.x120-x120

2017

Volltextzugriff (PDF)

IFCT-1001 CHIVA trial: A phase II study of carboplatin (Ca) plus pemetrexed (P) followed by P maintenance, as first-line therapy for human immunodeficiency virus (HIV)–associated advanced non-squamous non-small cell lung cancer (NS-NSCLC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9076-9076

2016

Volltextzugriff (PDF)

Pulmonary toxicity related to systemic treatment of nonsmall cell lung cancer

Cancer, 2011-07, Vol.117 (14), p.3069-3080

2011

Volltextzugriff (PDF)

Ultrasound contrast imaging of angiogenisis in a murine tumor model

The Journal of the Acoustical Society of America, 2008-05, Vol.123 (5_Supplement), p.3112-3112

2008

Volltextzugriff (PDF)

Angiogenesis and renal cell carcinoma

Bulletin du cancer, 2007-07, Vol.94 Spec No, p.S232

2007

Volltextzugriff (PDF)

Circulating tumor DNA (ctDNA) in advanced non-small cell lung cancer (NSCLC) from HIV-infected patients is associated to shorter overall survival (OS): Results from phase II trial (IFCT-1001 CHIVA)

Annals of oncology, 2018-10, Vol.29, p.viii507-viii507

2018

Volltextzugriff (PDF)

Predicting leakage of the VERCORS mock-up and concrete containment buildings - a digital twin approach

Acta Polytechnica CTU proceedings, 2022-03, Vol.33, p.78-84

2022

Volltextzugriff (PDF)

1405PCirculating tumor DNA (ctDNA) in advanced non-small cell lung cancer (NSCLC) from HIV-infected patients is associated to shorter overall survival (OS): Results from phase II trial (IFCT-1001 CHIVA)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(15)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Bronchial endoscopic ultrasound elastography: preliminary feasibility data

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

Gefitinib-Associated Propionibacterium acnes Pleural Empyema

Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial

FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study

Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy

Real-life use of nivolumab in non-small cell lung cancer: A multicentric cohort to determine its clinical efficacy and predictive factors of early progression

Antitumoral effect of low molecular weight heparin in localized lung cancer. A randomized phase III controlled trial

IFCT-1001 CHIVA trial: A phase II study of carboplatin (Ca) plus pemetrexed (P) followed by P maintenance, as first-line therapy for human immunodeficiency virus (HIV)–associated advanced non-squamous non-small cell lung cancer (NS-NSCLC)

Pulmonary toxicity related to systemic treatment of nonsmall cell lung cancer

Ultrasound contrast imaging of angiogenisis in a murine tumor model

Angiogenesis and renal cell carcinoma

Circulating tumor DNA (ctDNA) in advanced non-small cell lung cancer (NSCLC) from HIV-infected patients is associated to shorter overall survival (OS): Results from phase II trial (IFCT-1001 CHIVA)

Predicting leakage of the VERCORS mock-up and concrete containment buildings - a digital twin approach

1405PCirculating tumor DNA (ctDNA) in advanced non-small cell lung cancer (NSCLC) from HIV-infected patients is associated to shorter overall survival (OS): Results from phase II trial (IFCT-1001 CHIVA)

Aktive Filter

Suchergebnisse filtern